Therefore, loss of LXN attenuates adipocyte differentiation, lipogenesis, and thus provides protection for mice against HFD-induced obesity and metabolic dysfunction, which may lead to new insights on diet-induced obesity and identify LXN as a potential target for the treatment of obesity and its associated disorders. This evidence concerns the gene LXN and obesity disorder.